Fielmann Aktiengesellschaft (FLMNF)
USD 43.0
(0.0%)
USD 43.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 592.14 Million EUR | -2.26% |
| 2022 | 605.84 Million USD | 2.46% |
| 2021 | 591.31 Million USD | -0.03% |
| 2020 | 591.48 Million USD | 41.13% |
| 2019 | 419.1 Million USD | 50886.19% |
| 2018 | 822 Thousand EUR | -47.14% |
| 2017 | 1.55 Million EUR | 18.7% |
| 2016 | 1.31 Million EUR | 37.89% |
| 2015 | 950 Thousand EUR | -19.22% |
| 2014 | 1.17 Million EUR | 19.76% |
| 2013 | 982 Thousand EUR | -20.1% |
| 2012 | 1.22 Million EUR | -57.74% |
| 2011 | 2.9 Million EUR | -41.65% |
| 2010 | 4.98 Million EUR | -89.05% |
| 2009 | 45.53 Million EUR | -10.79% |
| 2008 | 51.04 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q2 | 518.9 Million EUR | 0.0% |
| 2023 Q4 | 592.14 Million EUR | 0.0% |
| 2023 FY | 592.14 Million EUR | -2.26% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q1 | 580.9 Million USD | -4.12% |
| 2023 Q2 | 576.07 Million USD | -0.83% |
| 2022 Q3 | 508.76 Million USD | 10.5% |
| 2022 Q1 | 455.94 Million EUR | -0.51% |
| 2022 Q2 | 460.4 Million EUR | 0.98% |
| 2022 Q4 | 605.84 Million USD | 19.08% |
| 2022 FY | 605.84 Million USD | 2.46% |
| 2021 Q1 | 424.91 Million EUR | -0.19% |
| 2021 FY | 591.31 Million USD | -0.03% |
| 2021 Q4 | 458.25 Million EUR | 1.66% |
| 2021 Q2 | 428.9 Million EUR | 0.94% |
| 2021 Q3 | 450.76 Million EUR | 5.1% |
| 2020 Q1 | 367.03 Million EUR | -1.54% |
| 2020 Q2 | 353.25 Million EUR | -3.75% |
| 2020 Q3 | 348.38 Million EUR | -1.38% |
| 2020 Q4 | 425.72 Million EUR | 22.2% |
| 2020 FY | 591.48 Million USD | 41.13% |
| 2019 FY | 419.1 Million USD | 50886.19% |
| 2019 Q2 | 380.49 Million EUR | 0.2% |
| 2019 Q3 | 382.18 Million EUR | 0.44% |
| 2019 Q1 | 379.72 Million EUR | 46094.77% |
| 2019 Q4 | 372.79 Million EUR | -2.46% |
| 2018 Q3 | 716 Thousand EUR | -49.44% |
| 2018 Q4 | 822 Thousand EUR | 14.8% |
| 2018 FY | 822 Thousand EUR | -47.14% |
| 2018 Q1 | 1.5 Million EUR | -2.96% |
| 2018 Q2 | 1.41 Million EUR | -6.16% |
| 2017 Q1 | 2.01 Million EUR | 53.76% |
| 2017 Q4 | 1.55 Million EUR | -34.08% |
| 2017 Q3 | 2.35 Million EUR | 10.65% |
| 2017 FY | 1.55 Million EUR | 18.7% |
| 2017 Q2 | 2.13 Million EUR | 5.84% |
| 2016 Q2 | 1.54 Million EUR | -14.19% |
| 2016 FY | 1.31 Million EUR | 37.89% |
| 2016 Q3 | 1.42 Million EUR | -7.65% |
| 2016 Q4 | 1.31 Million EUR | -8.01% |
| 2016 Q1 | 1.79 Million EUR | 89.16% |
| 2015 FY | 950 Thousand EUR | -19.22% |
| 2015 Q2 | 2.16 Million EUR | 1.26% |
| 2015 Q3 | 2.06 Million EUR | -4.53% |
| 2015 Q4 | 950 Thousand EUR | -54.04% |
| 2015 Q1 | 2.13 Million EUR | 81.8% |
| 2014 Q1 | 2.32 Million EUR | 137.07% |
| 2014 FY | 1.17 Million EUR | 19.76% |
| 2014 Q3 | 2.09 Million EUR | -11.36% |
| 2014 Q2 | 2.36 Million EUR | 1.37% |
| 2014 Q4 | 1.17 Million EUR | -43.79% |
| 2013 Q1 | 2.58 Million EUR | 110.01% |
| 2013 FY | 982 Thousand EUR | -20.1% |
| 2013 Q3 | 2.58 Million EUR | -12.09% |
| 2013 Q2 | 2.93 Million EUR | 13.75% |
| 2013 Q4 | 982 Thousand EUR | -61.95% |
| 2012 FY | 1.22 Million EUR | -57.74% |
| 2012 Q3 | - EUR | 0.0% |
| 2012 Q4 | 1.22 Million EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 Q1 | - EUR | -100.0% |
| 2011 Q3 | - EUR | 0.0% |
| 2011 Q4 | 2.9 Million EUR | 0.0% |
| 2011 FY | 2.9 Million EUR | -41.65% |
| 2011 Q1 | - EUR | -100.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 Q4 | 4.98 Million EUR | 0.0% |
| 2010 Q1 | - EUR | -100.0% |
| 2010 Q3 | - EUR | 0.0% |
| 2010 FY | 4.98 Million EUR | -89.05% |
| 2009 FY | 45.53 Million EUR | -10.79% |
| 2009 Q4 | 45.53 Million EUR | 0.0% |
| 2008 FY | 51.04 Million EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -118329.6% |
| Ansell Limited | 855.59 Million USD | 30.791% |
| Ansell Limited | 857.2 Million USD | 30.921% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -2542.154% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -2828407.284% |
| Psykey, Inc. | 1.01 Million USD | -58493.707% |
| ConvaTec Group Plc | 1.31 Billion USD | 54.817% |
| ConvaTec Group Plc | 1.31 Billion USD | 54.881% |
| Encision Inc. | 1.33 Million USD | -44315.475% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -25548.358% |
| Innovative MedTech Inc. | 1.87 Million USD | -31427.0% |
| LifePoint, Inc. | 446.74 Thousand USD | -132448.686% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | -10877.531% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | -26951.074% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -243939.828% |
| SmileDirectClub, Inc. | 871.79 Million USD | 32.077% |
| Sector 10, Inc. | 164 Thousand USD | -360965.854% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 12.146% |
| SheerVision, Inc. | 75 Thousand USD | -789430.667% |
| United Health Products, Inc. | 755.98 Thousand USD | -78227.595% |
| Vasamed, Inc. | 23.45 Thousand USD | -2525051.386% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | -21297.5% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -74808.128% |